DRDGOLD officer sells 5,275 shares at $2.75
DRDGOLD LTD officer exercises 11,721 deferred shares and sells 5,275 ordinary shares in a pooled sale, retaining the balance.
Rhea-AI Filing Summary
DRDGOLD LTD (DRD) reports that officer Mashatola Mpho exercised 11,721 Deferred Shares on August 13, 2026, which vested under the Company’s Single Incentive Plan and were settled one-for-one into Ordinary Shares for no consideration. A subsequent pooled sale on August 31 and September 1, 2026 disposed of 5,275 Ordinary Shares, with the remaining 6,446 Ordinary Shares retained in the reporting person’s own name. Following these events, the reporting person holds 72,900 Deferred Shares; no Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
3 txns
Insider
Mashatola Mpho
Role
Group Fin. & Business Dev. Mgr
Sold
5,275 shs ($15K)
Approx. gross sale proceeds
$15K
Approx. exercise cost
$0.00
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares F2, F3 | 5,275 | $2.7545 | $15K |
| Exercise | Deferred Shares F1, F4 | 11,721 | $0.00 | $0.00 |
| Exercise | Ordinary Shares F1 | 11,721 | $0.00 | $0.00 |
Holdings After Transaction:
Deferred Shares — 72,900 contracts (Direct);
Ordinary Shares — 39,868 shares (Direct)
Footnotes (4)
- F1. On August 13, 2026, 11,721 deferred shares of DRDGOLD Limited (the "Company") previously awarded to the Reporting Person under the Company's Single Incentive Plan (the "Deferred Shares") vested and were settled on a one-for-one basis in Ordinary Shares for no consideration.
- F2. Represents 5,275 Ordinary Shares sold on behalf of the Reporting Person as part of a pooled sale conducted on August 31 and September 1, 2026, following the vesting and settlement of 11,721 Deferred Shares described in footnote 1. The remaining 6,446 Ordinary Shares were transferred to and retained in the Reporting Person's own name.
- F3. The underlying transaction was denominated in South African rand ("ZAR"). For the purposes of this table, the price reported in United States dollars has been converted from ZAR using the South African Reserve Bank exchange rate in effect on the transaction date. The average sale price was ZAR 44.4764 per Ordinary Share.
- F4. The amount reported in Table II, Column 9 reflects the subsequent acquisition of Deferred Shares previously reported on the Reporting Person's Form 4 filed on August 27, 2026 and represents the Reporting Person's current holdings of Deferred Shares.
Key Figures
Deferred Shares vested and settled: 11,721 shares
Ordinary Shares sold: 5,275 shares
Average sale price (USD): $2.7545 per share
+3 more
6 metrics
Deferred Shares vested and settled
11,721 shares
Deferred Shares vested and settled into Ordinary Shares on August 13, 2026
Ordinary Shares sold
5,275 shares
Pooled sale conducted on August 31 and September 1, 2026
Average sale price (USD)
$2.7545 per share
Average price for 5,275 Ordinary Shares sold
Average sale price (ZAR)
ZAR 44.4764 per share
Average sale price in South African rand for Ordinary Shares sold
Ordinary Shares retained from vesting
6,446 shares
Portion of 11,721 vested Ordinary Shares retained in reporting person’s own name
Deferred Shares held after transactions
72,900 shares
Current holdings of Deferred Shares as reflected in Table II, Column 9
Key Terms
Deferred Shares, Single Incentive Plan, pooled sale, South African rand
4 terms
Single Incentive Plan financial
"previously awarded to the Reporting Person under the Company's Single Incentive Plan"
pooled sale financial
"sold on behalf of the Reporting Person as part of a pooled sale conducted"
South African rand financial
"The underlying transaction was denominated in South African rand ("ZAR")."
FAQ
What insider transactions did DRD executive Mashatola Mpho report on this Form 4?
The filing reports that 11,721 Deferred Shares vested on August 13, 2026 and were settled into Ordinary Shares for no consideration, and that 5,275 Ordinary Shares were then sold in a pooled sale on August 31 and September 1, 2026, with 6,446 shares retained.
Were DRDGOLD (DRD) insider transactions made under a Rule 10b5-1 trading plan?
No. The Rule 10b5-1 checkbox is not marked as affirming a plan, and the footnotes do not describe any trading plan, so no Rule 10b5-1 trading plan is reported for these transactions.
AI-generated analysis. How Rhea-AI works. Not financial advice.